Cargando…

Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report

BACKGROUND: Buprenorphine is a partial mu-opioid receptor agonist approved for the treatment of opioid dependence. The risk of withdrawal symptoms and wait time required to safely initiate buprenorphine provides challenges to both patients and providers. Microdose induction is proposed as a possible...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menard, Shannon, Jhawar, Archana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	College of Psychiatric & Neurologic Pharmacists 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582770/ https://www.ncbi.nlm.nih.gov/pubmed/34824962 http://dx.doi.org/10.9740/mhc.2021.11.369

Ejemplares similares

Outpatient Microdose Induction with Transdermal Buprenorphine: A Case Series
por: Menard, Shannon, et al.
Publicado: (2022)

Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
por: Rozylo, Jennifer, et al.
Publicado: (2020)

Successful Buprenorphine/Naloxone Low-dose Induction in Pregnancy: A Case Report
por: Coish, Rebecca, et al.
Publicado: (2023)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
por: Gawronski, Kristen M, et al.
Publicado: (2014)

Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan
por: Goshgarian, Gregory, et al.
Publicado: (2022)

Intravenous Buprenorphine Micro-dosing Induction in a Patient on Methadone Treatment: A Case Report
por: Crane, Kelly, et al.
Publicado: (2021)

Evaluation of drug-drug interaction between daclatasvir and methadone or buprenorphine/naloxone
por: Garimella, Tushar, et al.
Publicado: (2014)

Buprenorphine/naloxone induction for treatment of acute on chronic pain using a micro-dosing regimen: A case report
por: Sandhu, Raman, et al.
Publicado: (2019)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
por: Lund, Ingunn O., et al.
Publicado: (2013)

823 Evaluation of Drug-Drug Interaction between Asunaprevir and Methadone or Buprenorphine/Naloxone
por: Garimella, Tushar, et al.
Publicado: (2014)

Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method
por: Hämmig, Robert, et al.
Publicado: (2016)

Comment on “A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence During Pregnancy: Maternal and Neonatal Outcomes”
por: Newman, Robert G., et al.
Publicado: (2013)

Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
por: K. K., Adams, et al.
Publicado: (2022)

Buprenorphine Microdosing Cross Tapers: A Time for Change
por: Raheemullah, Amer, et al.
Publicado: (2022)

Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report
por: Kulaksızoğlu, Burak, et al.
Publicado: (2018)

The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
por: Hansen, Brenna, et al.
Publicado: (2022)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
por: McCormack, Lindsay, et al.
Publicado: (2021)

Microdosing and standard‐dosing take‐home buprenorphine from the emergency department: A feasibility study
por: Moe, Jessica, et al.
Publicado: (2020)

Low-dose naloxone provides an abuse-deterrent effect to buprenorphine
por: Webster, Lynn R, et al.
Publicado: (2015)

A Case Series of Spouses Undergoing Rapid Micro-Induction Technique of Buprenorphine Initiation from Methadone
por: Rampetsreiter, Kyle R., et al.
Publicado: (2023)

Use of nebulized naloxone to reverse methadone overdose – A case report and review of literature
por: Sameed, Muhammad, et al.
Publicado: (2019)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Reconsidering the Usefulness of Adding Naloxone to Buprenorphine
por: Blazes, Christopher K., et al.
Publicado: (2020)

Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial
por: Bastien, Gabriel, et al.
Publicado: (2022)

Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine
por: Bormann, Nicholas L., et al.
Publicado: (2023)

Intolerance of sublingual buprenorphine-naloxone during induction in a patient with end-stage liver disease: A case report
por: Behan, Jennifer, et al.
Publicado: (2016)

Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls
por: Rapeli, Pekka, et al.
Publicado: (2007)

Disparities in Emergency Department Naloxone and Buprenorphine Initiation
por: Papp, Joan, et al.
Publicado: (2023)

Using Microdosing to Induct Patients Into a Long-Acting Injectable Buprenorphine Depot Medication in Low Threshold Community Settings: A Case Study
por: Tay Wee Teck, Joseph, et al.
Publicado: (2021)

The Effects of Methadone and Buprenorphine on Testis of Rats
por: Corsi, Karen F.
Publicado: (2012)

Malmö Treatment Referral and Intervention Study—High 12-Month Retention Rates in Patients Referred from Syringe Exchange to Methadone or Buprenorphine/Naloxone Treatment
por: Bråbäck, Martin, et al.
Publicado: (2017)

Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs
por: Scott, Travis M., et al.
Publicado: (2021)

Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province
por: Sadek, Joseph, et al.
Publicado: (2022)

Buprenorphine as a safe alternative to methadone in a patient with acquired long QT syndrome: a case report
por: de Jong, I. M., et al.
Publicado: (2011)

A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
por: Simojoki, Kaarlo, et al.
Publicado: (2008)

Successful Management of Kratom Use Disorder With Buprenorphine and Naloxone
por: Arhin, Martin, et al.
Publicado: (2023)

Abuse of Synthetic Cannabinoids and Cathinones in a Patient on Buprenorphine-Naloxone Treatment: A Case Report
por: Awasthi, Harshal
Publicado: (2023)

'Diversion’ of methadone or buprenorphine: 'harm’ versus 'helping’
por: Havnes, Ingrid Amalia, et al.
Publicado: (2013)

Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada
por: Piske, Micah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h5fd81fu0ar3gdsipn4rq154v5